Vanguard Group’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Sell |
1,331,250
-171,306
| -11% | -$212K | ﹤0.01% | 3595 |
|
|
2025
Q1 | $1.83M | Sell |
1,502,556
-3,701
| -0.2% | -$4.52K | ﹤0.01% | 3516 |
|
|
2024
Q4 | $2.71M | Sell |
1,506,257
-18,611
| -1% | -$33.5K | ﹤0.01% | 3475 |
|
|
2024
Q3 | $7.76M | Buy |
1,524,868
+1,198,487
| +367% | +$6.1M | ﹤0.01% | 3082 |
|
|
2024
Q2 | $2.32M | Buy |
326,381
+15,895
| +5% | +$113K | ﹤0.01% | 3508 |
|
|
2024
Q1 | $851K | Hold |
310,486
| – | – | ﹤0.01% | 3865 |
|
|
2023
Q4 | $838K | Buy |
310,486
+665
| +0.2% | +$1.8K | ﹤0.01% | 3888 |
|
|
2023
Q3 | $815K | Buy |
309,821
+35,304
| +13% | +$92.8K | ﹤0.01% | 3906 |
|
|
2023
Q2 | $769K | Hold |
274,517
| – | – | ﹤0.01% | 3979 |
|
|
2023
Q1 | $796K | Hold |
274,517
| – | – | ﹤0.01% | 3989 |
|
|
2022
Q4 | $1.01M | Buy |
274,517
+125
| +0% | +$459 | ﹤0.01% | 3912 |
|
|
2022
Q3 | $886K | Hold |
274,392
| – | – | ﹤0.01% | 4045 |
|
|
2022
Q2 | $829K | Sell |
274,392
-30,406
| -10% | -$91.9K | ﹤0.01% | 4147 |
|
|
2022
Q1 | $2.56M | Sell |
304,798
-1,557
| -0.5% | -$13.1K | ﹤0.01% | 3860 |
|
|
2021
Q4 | $3.2M | Buy |
306,355
+106,761
| +53% | +$1.12M | ﹤0.01% | 3849 |
|
|
2021
Q3 | $3.59M | Buy |
+199,594
| New | +$3.59M | ﹤0.01% | 3837 |
|